BCL2L1 and amyotrophic lateral sclerosis: Given the elevated release of cytochrome c in ALS pathology, stability in the system is achieved by upregulating anti-apoptosis factors such as caspase-9 inhibitor, caspase-3 inhibitor, Bax inhibitor, and Bcl-2 homolog BCL-XL.